ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $326 | -41.5% | 7,060 | -49.2% | 0.04% | -19.6% |
| Q1 2023 | $557 | -99.9% | 13,890 | -33.7% | 0.05% | -40.7% |
| Q3 2022 | $868,000 | -10.9% | 20,950 | +105.0% | 0.09% | -12.2% |
| Q2 2021 | $974,000 | +286.5% | 10,220 | +462.5% | 0.10% | +139.0% |
| Q4 2020 | $252,000 | -59.2% | 1,817 | -79.6% | 0.04% | -59.4% |
| Q1 2019 | $617,000 | +174.2% | 8,900 | +93.2% | 0.10% | +65.6% |
| Q2 2016 | $225,000 | – | 4,606 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |